Tag: Biogen Inc
China seen as the following huge progress space for biotechs Biogen and Amgen
SunTrust initiated protection on Biogen and Amgen on Tuesday, ranking every inventory as a purchase based mostly on strong drug pipelines and progr [...]
Nvidia, Biogen, Kroger & extra
An worker pushes grocery carts outdoors a Kroger Co. grocery retailer in Louisville, Kentucky.Luke Sharrett | Bloomberg | Getty PicturesListed belo [...]
Traders should view Thursday’s market pullback ‘as a present’
CNBC's Jim Cramer on Thursday recognized numerous meals and drug shares which are price shopping for after the key indexes pulled again throughout [...]
Biotech shares win October, rallying 8%
A Biogen Idec lab technicianSuzanne Kreiter | The Boston Globe | Getty PhotographsBiotechnology shares are rising because the standout performers i [...]
Jim Cramer’s ‘Mad Cash’ recap & inventory picks Oct. 30, 2019
CNBC's Jim Cramer thinks traders want to start out contemplating consumption time and the federal authorities as a weight on Apple, Fb and differen [...]
Apple, Alphabet, Coca-Cola & extra
James QuinceyGetty PhotosListed here are the largest calls on Wall Avenue on Wednesday:UBS upgraded Coca-Cola to 'purchase' from 'impartial'UBS men [...]
Lightning won’t ever ‘strike’ index funds as Biogen, shares
CNBC's Jim Cramer on Tuesday doubled down on his doctrine that buyers ought to transcend simply proudly owning index funds and in addition purchase [...]
Jim Cramer’s ‘Mad Cash’ recap & inventory picks Oct. 22, 2019
CNBC's Jim Cramer explains why it is price selecting particular person shares in a world of buyers that place extra worth in index funds. The "Mad [...]
Jim Cramer’s ‘Mad Cash’ recap & inventory picks Oct. 22, 2019
CNBC's Jim Cramer explains why it is price selecting particular person shares in a world of buyers that place extra worth in index funds. The "Mad [...]
Biogen soars 40% on Alzheimer’s drug revival
Shares of Biogen soared almost 30% on Tuesday after the drugmaker introduced it was searching for regulatory approval for an Alzheimer's drug, aduc [...]
Biotech shares soar following shock Biogen drug announcement
Biotech shares surged after Biogen introduced plans to revive its Alzheimer's drug aducanumab.The iShares NASDAQ Biotechnology ETF gained greater t [...]